Enteris BioPharma appoints Gary A. Shangold as chief medical officer
With nearly 30 years of biopharmaceutical experience, Dr. Shangold joins Enteris as the company seeks to expand.
In addition to his position as CMO of Enteris, Dr. Shangold currently serves as the CEO of InteguRx Therapeutics.
Dr. Shangold held several senior roles in large biopharmaceutical companies, including a 10-year span at Johnson and Johnson Pharmaceutical.
He spent a decade in academia, on the faculty of The University of Chicago Pritzker School of Medicine, and then later at Massachusetts General Hospital and the Harvard School of Medicine. ■